VUC

melphalan

Created:	2023-08-18
Last modified:	2025-11-12

Find Related PDB Entry
1 entries where VUC is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	37
Chiral Atom Count	1
Bond Count	37
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	melphalan
Synonyms	(2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
Systematic Name (OpenEye OEToolkits)	(2~{S})-2-azanyl-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
Formula	C₁₃ H₁₈ Cl₂ N₂ O₂
Molecular Weight	305.2
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	N[CH](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O
SMILES	OpenEye OEToolkits	2.0.7	c1cc(ccc1CC(C(=O)O)N)N(CCCl)CCCl
Canonical SMILES	CACTVS	3.385	N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(O)=O
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(ccc1C[C@@H](C(=O)O)N)N(CCCl)CCCl
InChI	InChI	1.06	InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1
InChIKey	InChI	1.06	SGDBTWWWUNNDEQ-LBPRGKRZSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB01042
Name	Melphalan
Groups	investigational approved
Description	Melphalan is a nitrogen mustard or bischloroethylamine type alkylating agent.[L40928] It was first synthesized in the early 1950s by substituting L-phenylalanine for the methyl group on nitrogen mustard.[A261150, A261155] Melphalan is used in the treatment of multiple myeloma and ovarian carcinoma.[L40928] It is also used for high-conditioning before hematopoietic stem cell transplant.[L47890] It is also used to treat uveal melanoma with unresectable hepatic metastases.[L47895]
Synonyms	Alanine Nitrogen Mustard Melphalan hydrochloride Melphalanum L-Sarcolysin Phenylalanine mustard p-N-Bis(2-chloroethyl)amino-L-phenylalanine 4-[bis(2-chloroethyl)amino]-L-phenylalanine Melfalano L-Sarcolysin Melphalan 4-(Bis(2-chloroethyl)amino)-L-phenylalanine L-Sarcolysine p-L-Sarcolysin p-Di-(2-chloroethyl)amino-L-phenylalanine 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine L-PAM Sarcoclorin Phenylalanine nitrogen mustard L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine p-N,N-bis(2-chloroethyl)amino-L-phenylalanine Melfalan p-Bis(beta-chloroethyl)aminophenylalanine L-Phenylalanine mustard Phenylalanine mustard 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
Brand Names	Melphalan hydrochloride Melphalan for Injection Ivra Evomela Phelinun Taro-melphalan Hepzato Kit Alkeran Melphalan Hydrochloride Melphalan
Indication	Melphalan is indicated for use as a high-dose conditioning treatment prior to hematopoietic stem cell transplantation in patients with multiple myeloma.[L47890] It is also indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary.[L40928] Melphalan is a component of HEPZATO KIT, a liver-directed therapy indicated for the treatment of adults with uveal melanoma with unresectable hepatic metastases affecting less than 50% of the liver and no extrahepatic disease or extrahepatic disease limited to the bone, lymph nodes, subcutaneous tissues, or lung that is amenable to resection or radiation.[L47895]
Categories	Alkylating Activity Alkylating Drugs Amino Acids Amino Acids, Aromatic Amino Acids, Cyclic Amino Acids, Peptides, and Proteins Antineoplastic Agents Antineoplastic Agents, Alkylating Antineoplastic and Immunomodulating Agents Hydrocarbons, Halogenated Immunologic Factors Immunosuppressive Agents Mustard Compounds Myeloablative Agonists Myelosuppressive Agents Narrow Therapeutic Index Drugs Nitrogen Mustard Analogues Nitrogen Mustard Compounds Noxae Toxic Actions
ATC-Code	L01AA03
CAS number	148-82-3

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
DNA	-	unknown	cross-linking/alkylation
Albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	binder
Alpha-1-acid glycoprotein 1	MALSWVLTVLSLLPLLEAQIPLCANLVPVPITNATLDRITGKWFYIASAF...	unknown	binder
Solute carrier family 22 member 3	MPSFDEALQRVGEFGRFQRRVFLLLCLTGVTFAFLFVGVVFLGTQPDHYW...	unknown	inhibitor
Large neutral amino acids transporter small subunit 1	MAGAGPKRRALAAPAAEEKEEAREKMLAAKSADGSAPAGEGEGVTLQRNI...	unknown	substrate
Asc-type amino acid transporter 1	MAGHTQQPSGRGNPRPAPSPSPVPGTVPGASERVALKKEIGLLSACTIII...	unknown	substrate
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682